What Perimenopause Could Mean for Your Brain Health

Perimenopause may matter for brain health years after your periods stop. A recent Nature Medicine paper gives scientists new clues about how that link might work. Some of the changes they found were already present during the transition.

The study looked at changes linked with hormones, inflammation and how nerve cells work. It also looked at links with memory, thinking and Alzheimer’s disease later in life. That’s a lot to take in when you’re already wondering why your memory feels less reliable.

If word-finding and memory changes have left you concerned, the question is personal: what does this mean for your future?

The paper takes a closer look at what might link the hormone changes of midlife with brain health years later. Its findings could help guide the search for better ways to protect women’s brain health.

The clues were there during perimenopause

Madeline Wood Alexander and her team first compared blood samples from 80 women aged 43 to 58. The group included women before, during and after the menopause transition. Twenty-six were in perimenopause. 1

The team looked at proteins involved in inflammation, how nerve cells send signals, and changes linked with Alzheimer’s disease. Proteins do many jobs in the body. Their levels in the blood can give clues about what’s happening inside it.

They found a pattern that differed across the three groups. The difference was already there in the women in perimenopause.

The hormone transition may be part of the story of brain health years later.

The team also checked findings in a separate UK Biobank sample of 2,814 women. They compared women after menopause with women before or during the transition, matched for age. Many of the shared protein findings held up, though not all of them did. 1

That adds weight to the finding. It also gives future studies a clearer starting point than a single small sample could provide.

Hormones were an important part of the picture

The pattern tracked more closely with hormone levels than with age.

Lower estrogen was linked with higher levels of some proteins involved in inflammation. Higher FSH was linked with proteins involved in nerve-cell function and Alzheimer’s biology. FSH is one of the hormones that changes as the ovaries become less active. 1

This matters because two women can be the same age and at different points in the transition. Their age alone won’t describe what’s happening with their hormones.

The findings give scientists more precise things to study. How might hormone changes relate to inflammation? Which changes could affect brain health over time? And which might respond to treatment?

The team measured proteins in blood, so this wasn’t a direct look inside anyone’s brain. The results help show what needs a closer look.

Where Alzheimer’s enters the story

The team then looked at related protein patterns in four separate groups of older women. They asked whether the pattern was linked with memory, thinking and the risk of dementia.

Higher scores were linked with poorer results on tests of memory and thinking. In one large group followed over time, a higher score was also linked with a small increase in Alzheimer’s dementia risk. The study didn’t find a clear link with dementia overall. 1

Those details matter when a headline puts menopause and dementia together. The results suggest that changes linked with the menopause transition may also matter for brain health later. The links weren’t the same for every type of dementia. The findings don’t provide a forecast for one woman.

The next step is to follow women through the transition and beyond. Scientists need to learn which changes last, which settle, and which could help them spot risk earlier.

How knowing this could help

For a woman in perimenopause, the promise is care that takes this transition into account when thinking about brain health in the years ahead.

To develop that care, scientists need to know what they might be able to change. This paper gives them more precise clues to study. Some concern inflammation. Others involve the ways nerve cells work and send signals.

That could help them find targets for future treatments. It could also help them build tests that show which women might need extra support.

A useful test would need to do more than spot a difference between groups. It would need to help guide care. Scientists would also need to show that acting on the results improves health.

The study also didn’t test whether hormone therapy changes these findings. That’s a question treatment studies would need to answer. 1

There are still questions to work through. But the progress is concrete: the team has found signals that other studies can check and follow over time.

Better understanding can lead to better care

If you’re concerned about your brain health during perimenopause, this research gives you something specific to understand. Scientists are looking at how the hormone changes of midlife could relate to brain health much later. They’re finding clues that may help explain that link.

The aim is to learn who may need more support, what might help, and when it could make a difference.

For a woman today, this paper deepens understanding and helps lead the way towards earlier, more targeted ways to protect brain health.

It gives scientists new clues about what changes during perimenopause. Those clues can help guide the search for better tests and treatments that could support women through the transition and in the years ahead.

The research behind this post

Wood Alexander M, Rabin JS, Caunca M, et al. Blood proteomics of menopause map to brain aging and dementia risk. Nature Medicine. Published 22 September 2026. PMID 42773212. DOI: 10.1038/s41591-026-04648-4.